用Trikine免疫治疗药物重新连接细胞表面的STAT信号
Grayson E Rodriguez1,2, Yang Zhao2, Yoko Nishiga3,4,5
1Immunology Program, Stanford University, Stanford, CA, USA.
概括
研究人员设计了新的"Trikines"以通过形成三链受体复合体来精确控制免疫细胞信号. 这种免疫疗法方法在癌症治疗和增强免疫反应的临床前模型中显示出希望.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 细胞因子通过二元化受体链来激活免疫细胞,从而导致Janus激酶和STAT因子的激活.
- 目前的细胞因子疗法有局限性和治疗责任.
- STAT转录因子调节重要的免疫细胞功能.
研究的目的:
- 为了设计新的分子,称为"Trikines",能够诱导特定的STAT转录信号程序.
- 在细胞表面创建定制的三链细胞因子受体复合体.
- 探索特里基因作为一种潜在的免疫治疗策略.
主要方法:
- 工程三基因组装互白素-2 (IL-2),互白素-10 (IL-10) 和互白素-21 (IL-21) 受体的三基组合.
- 同时激活化STAT5 (pSTAT5) 和化STAT3 (pSTAT3) 信号通路.
- 在临床前癌症模型中评估Trikine的疗效.
主要成果:
- 与天然细胞因子相比,三基因诱导了不同的pSTAT5和pSTAT3签名.
- 一种基于IL-2的Trikine促进了T细胞干细胞,抑制了分化,并改善了无毒性的瘤控制.
- 一种基于IL-10的Trikine在免疫学上"冷"的瘤中增强了免疫透,在小细胞肺癌和胰腺癌模型中显示出有效性.
结论:
- 三基尼提供了一种方法来定制STAT信号签名,而不需要细胞工程.
- 工程三基尼在免疫治疗的临床前模型中展示了治疗潜力.
- 这种方法可以克服目前基于细胞因子的治疗方法的局限性.
相关概念视频
Cell-surface Signaling
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
What is Cell Signaling?
Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
Overview of Cell Signaling
Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate with the environment.
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...


